News
A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity who were taking the drug were able to shed more than a fifth of their ...
Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...
Rybelsus contains the active ingredient semaglutide. It belongs to the glucagon-like peptide-1 (GLP-1) receptor agonist drug class. (A drug class is a group of medications that work in a similar way.) ...
Its active ingredient, semaglutide, is a synthetic version of the natural hormone GLP-1. This hormone plays a vital role in regulating blood sugar levels. You can only get Ozempic on prescription ...
Ozempic (semaglutide) belongs to a group of medications called GLP-1 receptor agonists that help treat type 2 diabetes. This medication is a once-weekly injection that helps regulate blood sugar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results